Intravenous; mCRPC: Metastatic castration-resistant prostate cancer; P: Placebo ... the incidence of skeletal-related events (SREs) in bone metastatic CRPC (mCRPC). Denosumab compared with ...

[25] The preferential metastatic sites in 316 patients with PC were bone (89.5% ... BM: Brain metastasis; CRPC: Castration-resistant prostate cancer; CT: Computed tomography; NA: Not assessed ...

Professor Adrian Crellin, 70, noticed blood in his urine and promptly sought medical attention from his GP, leading to a ...

There are currently, however, two radioligands that are United States Food and Drug Administration (FDA)-approved for the treatment of mCRPC patients: Patients with advanced prostate cancer are at ...

A top UK doctor has been left ‘devastated’ after being diagnosed with an incurable cancer he’s spent his life treating.

More men are getting checked for prostate cancer and realising they have the disease at an early stage, but charity Prostate ...

Prostate cancer is one of the most prevalent cancers among men and poses a significant health concern, with its incidence on ...

One of the UK's leading radiotherapy experts, Professor Adrian Crellin, has been diagnosed with incurable cancer and ...

Two metastatic lesions in the middle section ... that are used to diagnose prostate cancer. Source: Prostate Cancer UK A follow-up bone scan identified a tumour in the man's right shinbone ...

Explore the role of the extracellular matrix (ECM) in prostate cancer progression and discover natural therapies, including ...